Phase 3 Study to Assess Efficacy, Safety & Tolerability of OCU410 For Geographic Atrophy Secondary to Dry AMD

Clinical trial NCT07770828 · RECRUITING

Trial details

NCT number: NCT07770828
Sponsor: Ocugen
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Dry Age-related Macular Degeneration

Start date: 2026-08-11
Primary completion: 2028-07-30
Enrollment: 237

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.